Healthcare, Regulatory and Reimbursement Landscape - Indonesia



Summary



GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - Indonesia”. The report is an essential source of information and analysis, and identifies the key trends in Indonesia’s healthcare market. It also provides an insight into the demographic, regulatory, and reimbursement landscape, and the overall healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation in the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2010, Indonesia had a population of approximately 238 million, placing it in fourth position globally. The population growth rate is however declining due to a decrease in the birth rate and an increase in net emmigration. In 2010, the working-age population in Indonesia accounts for the majority of the overall population unlike China and Japan. In order to take full advantage of this, the government is currently working on developing human capital by increasing spending on health and education. Indonesia’s pharmaceutical market was estimated to be worth $3.8 billion in 2010, and is expected to reach approximately $9.6 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 9.7%. In 2010, the medical device market of Indonesia was worth approximately $573m. Indonesia manufactures a number of medical equipments such as hospital beds, disposable supplies, and wheelchairs; however, it imports more than 90% of its medical devices.

The positive trend in the healthcare market of Indonesia can be attributed primarily to -
- Increasing coverage of healthcare insurance;
- Improved access to healthcare facilities;
- Increasing elderly population;
- Government initiatives regarding the management and prevention of communicable diseases.



Scope


The report provides information on Indonesia’s healthcare, regulatory, and reimbursement landscape, including -
- Overview of the pharmaceutical and medical devices market, including market size and segmentation, and the key drivers and barriers;
- Profiles and SWOT analysis of the major players in the pharmaceutical market, namely PT Kalbe Farma Tbk, PT Tempo Scan Pacific Tbk, Kimia Farma, Sanbe Farma, and Soho Group;
- Insightful review of the reimbursement and regulatory landscape, with details of the healthcare reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices for indonesia;
- Detailed analysis of Indonesia’s political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditure;
- An overview of the opportunities for and challenges to growth in the healthcare market.



Reasons to buy


This will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the healthcare market;
- Drive revenues by understanding key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments, and companies likely to impact the healthcare market in the future;
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors;
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnerships;
- Identify, understand and capitalize on the opportunities and challenges in Indonesia’s healthcare market.

Table Of Contents

Table of Contents
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 Report Guidance 11
3 Overview of the Pharmaceutical and Medical Device Market 12
3.1 Pharmaceutical Market 12
3.1.1 Market Overview 12
3.1.2 Supply Channels 15
3.1.3 Market Segments 16
3.1.4 Major Drug Classes 19
3.1.5 Major Players 25
3.2 Medical Device Market 41
3.2.1 Market Overview 41
3.3 Market Drivers and Barriers 42
3.3.1 Drivers 42
3.3.2 Barriers 42
4 Market Access 44
4.1 Reimbursement and Payer Landscape 44
4.1.1 Overview of Healthcare System 44
4.1.2 Reimbursement Process 45
4.1.3 Overview of Insurance Providers 47
4.1.4 Patients Share of Healthcare Spending 48
4.1.5 Healthcare Price Trends 50
4.1.6 Pricing Policies 50
4.2 Regulatory Landscape 51
4.2.1 Overview of Regulatory Agencies 51
4.2.2 Market Authorization Procedure for Pharmaceutical Products 52
4.2.3 New Medical Device Approval Process 53
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 55
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 55
4.2.6 Intellectual Property Rights 56
4.2.7 Clinical Trial Regulations 58
4.2.8 Pharmaceutical Advertising Regulations 60
4.2.9 Pharmacy Regulations 60
4.2.10 Labeling and Packaging Regulations 61
5 Country Analysis 62
5.1 Political Environment 62
5.1.1 Political Structure 62
5.1.2 Analysis of the Current Political Environment 62
5.1.3 Healthcare Policy Initiatives 63
5.2 Economic Landscape 64
5.3 Economic Indicators 65
5.3.1 Gross Domestic Product 65
5.3.2 Gross National Income 70
5.3.3 Inflation 71
5.3.4 Currency Exchange Rate 75
5.3.5 Foreign Direct Investment 76
5.3.6 Foreign Exchange Reserves 77
5.3.7 Trade Balance 78
5.3.8 Government Structural Balance 80
5.3.9 Government Gross Debt 82
5.3.10 Major Industries 84
5.4 Demographics 85
5.4.1 Population 85
5.4.2 Education and Literacy 101
5.4.3 Employment 103
5.4.4 Disease Burden 104
5.5 Healthcare Infrastructure 106
5.5.1 Healthcare Facilities 106
5.5.2 Healthcare Parameters 113
5.5.3 Environmental Health 115
5.5.4 Healthcare Personnel 120
5.6 Healthcare Expenditure 123
5.6.1 Overview of the Healthcare System 123
5.6.2 Major Components of Healthcare Spending 125
5.6.3 Share of Public and Private Sectors 126
5.7 Trade Associations 127
5.7.1 International Pharmaceutical Manufacturers Group 127
5.7.2 Indonesia Pharmaceutical Association 127
5.7.3 Indonesia Medical Association 127
5.8 Trade Fairs 128
6 Opportunities and Challenges 129
6.1 Opportunities 129
6.2 Challenges 130
7 Appendix 132
7.1 Abbreviations 132
7.2 Bibliography 134
7.3 Methodology 140
7.3.1 Coverage 140
7.3.2 Secondary Research 140
7.3.3 Forecasting 140
7.3.4 Primary Research 141
7.3.5 Expert Panel Validation 141
7.4 Contact Us 141
7.5 Disclaimer 141
List of Tables

1.1 List of Tables
Table 1: Pharmaceutical Market ($bn), Indonesia, 2005-2010 13
Table 2: Pharmaceutical Market ($bn), Indonesia, Forecast, 2011-2020 14
Table 3: Price Margins of Distribution Channel (%), Indonesia, 2011 15
Table 4: Pharmaceutical Distribution, Indonesia, Share (%), 2005 16
Table 5: OTC Pharmaceutical Market ($bn), Indonesia, 2005-2010 18
Table 6: Pharmaceutical Market Share (%), Indonesia, 2005-2010 18
Table 7: Major Drug Classes, Indonesia, Segment Market Share (%), 2005 19
Table 8: Antibiotics, Indonesia, Segment Market Share (%), 2005 20
Table 9: Respiratory Drugs, Indonesia, Segment Market Share (%), 2005 21
Table 10: Neuromuscular Drugs, Indonesia, Segment Market Share (%), 2005 22
Table 11: Vitamins and Minerals, Indonesia, Segment Market Share (%), 2005 23
Table 12: Dermatological Drugs, Indonesia, Segment Market Share (%), 2005 24
Table 13: Major Products, PT Kalbe Farma Tbk, Revenues ($m), 2010 25
Table 14: Major Products, PT Tempo Scan Pacific Tbk, 2011 29
Table 15: Major Products, Kimia Farma, Revenues ($m), 2010 32
Table 16: Major Products, Sanbe Farma, 2011 35
Table 17: Major Products, Soho Group, 2011 38
Table 18: Public Health Insurance Schemes, Indonesia, Population Enrolled (m), 2010 48
Table 19: Healthcare Spending, Indonesia, Patient's Share (%), 2005-2010 49
Table 20: Inflation, Healthcare, Indonesia, 2005-2010 50
Table 21: Impact of Natural Calamities, Indonesia, 1996-2009 64
Table 22: GDP Per Capita ($), Indonesia, 2005-2010 66
Table 23: GDP Per Capita ($), Indonesia, Forecast, 2011-2020 67
Table 24: GDP, Indonesia, Annual Growth (%), 2005-2010 68
Table 25: GDP, Indonesia, Annual Growth (%), Forecast, 2011-2020 69
Table 26: GNI Per Capita ($), Indonesia, 2005-2010 70
Table 27: Average Consumer Price Index, Indonesia, 2005-2010 71
Table 28: Average Consumer Price Index, Indonesia, Forecast, 2011-2020 72
Table 29: Average Consumer Price, Indonesia, Annual Change (%), 2005-2010 73
Table 30: Average Consumer Price, Indonesia, Annual Change (%), Forecast, 2011-2020 74
Table 31: Currency Exchange Rate (IDR/$), Indonesia, 2005-2010 75
Table 32: Foreign Direct Investment ($bn), Indonesia, 2005-2010 76
Table 33: Foreign Exchange Reserves ($bn), Indonesia, 2005-2010 77
Table 34: Imports of Goods and Services ($bn), Indonesia, 2005-2010 78
Table 35: Exports of Goods and Services ($bn), Indonesia, 2005-2010 79
Table 36: General Government Structural Balance ($bn), Indonesia, 2005-2010 80
Table 37: General Government Structural Balance ($bn), Indonesia, Forecast, 2011-2020 81
Table 38: General Government Gross Debt ($bn), Indonesia, 2005-2010 82
Table 39: General Government Gross Debt ($bn), Indonesia, Forecast, 2011-2020 83
Table 40: Major Industries, Indonesia, Value Added ($bn), 2009 85
Table 41: Population (m), Indonesia, 2005-2010 86
Table 42: Population (m), Indonesia, Forecast, 2011-2020 86
Table 43: Urban and Rural Population, Indonesia, Share (%), 2005-2010 87
Table 44: Urban and Rural Population, Indonesia, Share (%), Forecast, 2011-2020 88
Table 45: Age Groups, Indonesia, Population Distribution (%), 2005-2010 89
Table 46: Age Groups, Indonesia, Population Distribution (%), Forecast, 2011-2020 90
Table 47: Births (Per 1,000 Population), Indonesia, 2005-2010 91
Table 48: Mortality (Per 1,000 Population), Indonesia, 2005-2010 92
Table 49: Major Causes of Mortality (‘000s), Indonesia, 2008 93
Table 50: Children Table 51: Immunization Rate (%), Indonesia, 2005-2010 95
Table 52: Major Causes of Male Mortality (‘000s), Indonesia, 2008 96
Table 53: Major Causes of Female Mortality (‘000s), Indonesia, 2008 97
Table 54: Gender Ratio (M/F), Indonesia, 2005-2010 98
Table 55: Life Expectancy at Birth (Years), Indonesia, 2005-2010 99
Table 56: Life Expectancy at Birth (Years), Indonesia, Forecast, 2011-2020 100
Table 57: Illiteracy by Age Group (%), Indonesia, 2010 101
Table 58: School Enrollment by Age Group, Indonesia, 2010 102
Table 59: Unemployment (%), Indonesia, 2005-2010 103
Table 60: Major Causes of Hospitalization, Indonesia, Inpatients (Per 100,000 Population), 2007 104
Table 61: Major Diseases, Indonesia, DALY (Per 100,000 Population), 2004 105
Table 62: Public and Private Hospitals, Indonesia, 2005-2010 106
Table 63: Public and Private Hospitals, Indonesia, Forecast, 2011-2020 107
Table 64: Health Centers (‘000s), Indonesia, 2005-2010 108
Table 65: Health Centers (‘000s), Indonesia, Forecast, 2011-2020 109
Table 66: Hospitals by Type of Care, Indonesia, 2008 110
Table 67: General Hospital Beds (‘000s), Indonesia, 2005-2010 111
Table 68: General Hospital Beds (‘000s), Indonesia, Forecast, 2011-2020 112
Table 69: Beds (Per 100,000 Population), Indonesia, 2005-2010 113
Table 70: Physicians (Per 100,000 Population), Indonesia, 2005-2010 114
Table 71: CO2 Emission (Metric Tons), Indonesia, 2005-2010 115
Table 72: PM-10 Emissions (µgm/m3), Indonesia, 2005-2010 116
Table 73: Drinking Water Facilities, Indonesia, Share (%), 2008 117
Table 74: Organic Water Pollutant Emissions (Metric Tons Per Day), 2005-2010 118
Table 75: Waste Handling, Indonesia, Share (%), 2008 119
Table 76: Nurses (Per 100,000 Population), Indonesia, 2005-2010 120
Table 77: Pharmacists (Per 100,000 Population), Indonesia, 2005-2010 121
Table 78: Dentists (Per 100,000 Population), Indonesia, 2005-2010 122
Table 79: Healthcare Expenditure (% of GDP), Indonesia, 2005-2010 123
Table 80: Healthcare Expenditure (% of GDP), Indonesia, Forecast, 2011-2020 124
Table 81: Healthcare Expenditure, Indonesia, Share of Components (%), 2008 125
Table 82: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2005-2010 126
Table 83: Major Healthcare Trade Fairs, Indonesia, 2011-2012 12
List of Figures

1.2 List of Figures
Figure 1: Pharmaceutical Market ($bn), Indonesia, 2005-2010 13
Figure 2: Pharmaceutical Market ($bn), Indonesia, Forecast, 2011-2020 14
Figure 3: Distribution Channels, Indonesia, 2011 15
Figure 4: Pharmaceutical Distribution, Indonesia, Share (%), 2005 16
Figure 5: OTC Pharmaceutical Market ($bn), Indonesia, 2005-2010 17
Figure 6: Pharmaceutical Market Share (%), Indonesia, 2005-2010 18
Figure 7: Major Drug Classes, Indonesia, Segment Market Share (%), 2005 19
Figure 8: Antibiotics, Indonesia, Segment Market Share (%), 2005 20
Figure 9: Respiratory Drugs, Indonesia, Segment Market Share (%), 2005 21
Figure 10: Neuromuscular Drugs, Indonesia, Segment Market Share (%), 2005 22
Figure 11: Vitamins and Minerals, Indonesia, Segment Market Share (%), 2005 23
Figure 12: Dermatological Drugs, Indonesia, Segment Market Share (%), 2005 24
Figure 13: Drivers and Barriers, Healthcare Market, Indonesia, 2011 43
Figure 14: History of Health Insurance System, Indonesia, 1968-2008 44
Figure 15: Process for Addition to Hospital Drug Formulary, Indonesia, 2011 46
Figure 16: Health Insurance Coverage, Indonesia, 2010 47
Figure 17: Healthcare Spending, Indonesia, Patient's Share (%), 2005-2010 49
Figure 18: Inflation, Healthcare, Indonesia, 2005-2010 50
Figure 19: Structure of the National Agency of Drug and Food Control, Indonesia, 2011 51
Figure 20: Drug Market Authorization Process, Indonesia, 2011 53
Figure 21: Medical Device Approval Process, Indonesia, 2011 54
Figure 22: Licensing Process for Manufacturing, Indonesia, 2011 55
Figure 23: Structure of the Directorate General of Intellectual Property Office, Indonesia, 2011 56
Figure 24: Patent Approval Process, Indonesia, 2011 57
Figure 25: Clinical Trial Regulation Process, Indonesia, 2011 59
Figure 26: GDP Per Capita ($), Indonesia, 2005-2010 66
Figure 27: GDP Per Capita ($), Indonesia, Forecast, 2011-2020 67
Figure 28: GDP, Indonesia, Annual Growth (%), 2005-2010 68
Figure 29: GDP, Indonesia, Annual Growth (%), Forecast, 2011-2020 69
Figure 30: GNI Per Capita ($), Indonesia, 2005-2010 70
Figure 31: Average Consumer Price Index, Indonesia, 2005-2010 71
Figure 32: Average Consumer Price Index, Indonesia, Forecast, 2011-2020 72
Figure 33: Average Consumer Price, Indonesia, Annual Change (%), 2005-2010 73
Figure 34: Average Consumer Price, Indonesia, Annual Change (%), Forecast, 2011-2020 74
Figure 35: Currency Exchange Rate (IDR/$), Indonesia, 2005-2010 75
Figure 36: Foreign Direct Investment ($bn), Indonesia, 2005-2010 76
Figure 37: Foreign Exchange Reserves ($bn), Indonesia, 2005-2010 77
Figure 38: Imports of Goods and Services ($bn), Indonesia, 2005-2010 78
Figure 39: Exports of Goods and Services ($bn), Indonesia, 2005-2010 79
Figure 40: General Government Structural Balance ($bn), Indonesia, 2005-2010 80
Figure 41: General Government Structural Balance ($bn), Indonesia, Forecast, 2011-2020 81
Figure 42: General Government Gross Debt ($bn), Indonesia, 2005-2010 82
Figure 43: General Government Gross Debt ($bn), Indonesia, Forecast, 2011-2020 83
Figure 44: Major Industries, Indonesia, Value Added ($bn), 2009 84
Figure 45: Population (m), Indonesia, 2005-2010 85
Figure 46: Population (m), Indonesia, Forecast, 2011-2020 86
Figure 47: Urban and Rural Population, Indonesia, Share (%), 2005-2010 87
Figure 48: Urban and Rural Population, Indonesia, Share (%), Forecast, 2011-2020 88
Figure 49: Age Groups, Indonesia, Population Distribution (%), 2005-2010 89
Figure 50: Age Groups, Indonesia, Population Distribution (%), Forecast, 2011-2020 90
Figure 51: Births (Per 1,000 Population), Indonesia, 2005-2010 91
Figure 52: Mortality (Per 1,000 Population), Indonesia, 2005-2010 92
Figure 53: Major Causes of Mortality (‘000s), Indonesia, 2008 93
Figure 54: Children Figure 55: Immunization Rate (%), Indonesia, 2005-2010 95
Figure 56: Major Causes of Male Mortality (‘000s), Indonesia, 2008 96
Figure 57: Major Causes of Female Mortality (‘000s), Indonesia, 2008 97
Figure 58: Gender Ratio (M/F), Indonesia, 2005-2010 98
Figure 59: Life Expectancy at Birth (Years), Indonesia, 2005-2010 99
Figure 60: Life Expectancy at Birth (Years), Indonesia, Forecast, 2011-2020 100
Figure 61: Illiteracy by Age Group (%), Indonesia, 2010 101
Figure 62: School Enrollment by Age Group, Indonesia, 2010 102
Figure 63: Unemployment (%), Indonesia, 2005-2010 103
Figure 64: Major Causes of Hospitalization, Indonesia, Inpatients (Per 100,000 Population), 2007 104
Figure 65: Major Diseases, Indonesia, DALY (Per 100,000 Population), 2004 105
Figure 66: Public and Private Hospitals, Indonesia, 2005-2010 106
Figure 67: Public and Private Hospitals, Indonesia, Forecast, 2011-2020 107
Figure 68: Health Centers (‘000s), Indonesia, 2005-2010 108
Figure 69: Health Centers (‘000s), Indonesia, Forecast, 2011-2020 109
Figure 70: Hospitals by Type of Care, Indonesia, 2008 110
Figure 71: General Hospital Beds (‘000s), Indonesia, 2005-2010 111
Figure 72: General Hospital Beds (‘000s), Indonesia, Forecast, 2011-2020 112
Figure 73: Beds (Per 100,000 Population), Indonesia, 2005-2010 113
Figure 74: Physicians (Per 100,000 Population), Indonesia, 2005-2010 114
Figure 75: CO2 Emission (Metric Tons), Indonesia, 2005-2010 115
Figure 76: PM-10 Emissions (µgm/m3), Indonesia, 2005-2010 116
Figure 77: Drinking Water Facilities, Indonesia, Share (%), 2008 117
Figure 78: Organic Water Pollutant Emissions (Metric Tons Per Day), 2005-2010 118
Figure 79: Waste Handling, Indonesia, Share (%), 2008 119
Figure 80: Nurses (Per 100,000 Population), Indonesia, 2005-2010 120
Figure 81: Pharmacists (Per 100,000 Population), Indonesia, 2005-2010 121
Figure 82: Dentists (Per 100,000 Population), Indonesia, 2005-2010 122
Figure 83: Healthcare Expenditure (% of GDP), Indonesia, 2005-2010 123
Figure 84: Healthcare Expenditure (% of GDP), Indonesia, Forecast, 2011-2020 124
Figure 85: Healthcare Expenditure, Indonesia, Share of Components (%), 2008 125
Figure 86: Healthcare Expenditure, Indonesia, Public-Private Share (%), 2005-2010 126
Figure 87: Opportunities and Challenges, Healthcare Market, Indonesia, 2011 131

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 7 500
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new report, which provides comprehensive analysis ...

Ambulance and Emergency Equipment: Global Markets

Ambulance and Emergency Equipment: Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

The ambulance equipment industry experienced significant growth during the last decade due to the recession, an unstable health insurance environment, natural calamities and technological advancements. ...

Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Hospital Stretchers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

Hospital stretchers are apparatus used to transport a patient from one location to another, inside or outside of medical infrastructure premises. In addition to patient transportation, hospital stretchers ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.